FindTrial
Sign In

To determine the effectiveness of Siddha management in Type 2 Diabetic patients

Effectiveness of Siddha management in Type 2 Diabetic patients (Madhumegam) at NIS OPD - A Retrospective Study - Nil

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040141
Enrollment
100
Registered
2022-02-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E11- Type 2 diabetes mellitus

Interventions

None listed

Sponsors

Ayothidass Pandithar Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with Type 2 Diabetes mellitus 2.Patient taking Siddha medicines for DM for minimum period of 1 year.

Exclusion criteria

Exclusion criteria: 1.Patient with Irregular medication 2.Patient not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
To determine the effectiveness of Siddha medicines taken by type 2 Diabetes patients.Risk of other systemic diseases will be assessed by monitoring the Lipid profile.Timepoint: 6 months—

Secondary

MeasureTime frame
NILTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr P Shanmugapriya

National Institute of Siddha

archuarchana6024@gmail.com9790075305

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026